Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor

INTRODUCTION: Immune checkpoint blockade (ICB)-based therapy is revolutionizing cancer treatment by fostering successful immune surveillance and effector cell responses against various types of cancers. However, patients with HER2+ cancers are yet to benefit from this therapeutic strategy. Precisely...

Descripción completa

Detalles Bibliográficos
Autores principales: Padmanabhan, Regina, Kheraldine, Hadeel, Gupta, Ishita, Meskin, Nader, Hamad, Anas, Vranic, Semir, Al Moustafa, Ala-Eddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769711/
https://www.ncbi.nlm.nih.gov/pubmed/36568154
http://dx.doi.org/10.3389/fonc.2022.977664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769711/
https://www.ncbi.nlm.nih.gov/pubmed/36568154
http://dx.doi.org/10.3389/fonc.2022.977664

Ejemplares similares